Home » Clinical Trials »  Search Clinical Trials

Therapeutic Areas:  |  Endocrinology  |  Family Medicine

Search Medical Condition
Please enter condition
Please choose location

Diabetes Mellitus, Type 1 Clinical Trials

A listing of Diabetes Mellitus, Type 1 medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

RESULTS

Found (130) clinical trials

A research study is evaluating a Smartphone app for people with Type 1 or Type 2 Diabetes.

Phase N/A

This will be a Phase 2b, multicenter, randomized, double blind, titration clinical study, evaluating the efficacy and safety in the HDV Insulin Lispro Group versus Insulin Lispro Group in patients with type 1 diabetes over a 26 week treatment period. The patients will be randomized using a centrally allocated randomization ...

Phase N/A

Primary objective: To demonstrate that morning injection of Toujeo compared to Lantus will provide better glycemic control evaluated by Continuous Glucose Monitoring (CGM) in adult patients with type 1 diabetes mellitus. Secondary objective(s): To demonstrate that treatment with Toujeo compared to Lantus will provide lower incidence rate of nocturnal symptomatic ...

Phase

We are seeking volunteers who are diagnosed with Type 1 Diabetes and who are currently treating with Lantus or Levemir and a bolus insulin. This study is comparing the effectiveness of investigational insulin mixed with Humalog that may improve blood sugar levels. All participants will remain on either their Lantus ...

Phase

We are looking for participants to take part in a clinical research study to determine if a morning injection of Toujeo compared to Lantus will provide better glycemic control in adult patients with type 1 diabetes.

Phase N/A

Doctors in your area are evaluating the safety and effectiveness of a study medication to find out if it has the potential to maintain beta cell (insulin producing) function in the pancreas of children and young adults who have type 1 diabetes.

Phase N/A

Children and young adults who have Type 1 Diabetes are invited to participate in a research study being conducted by Montefiore Medical Center.

Phase N/A

The maximum duration for GLP1-RA patients will be approximately 29 weeks: an up to 2 week screening period, a 26 week treatment period (either randomized or uncontrolled), and a 3 or 9 day post-treatment safety followup period. Maximum duration for FRC patients will be approximately 55 weeks: an up to ...

Phase

This study is being conducted to see if an investigational rapid acting insulin works as well as the already FDA approved NovoLog, in combination with Lantus to improve daily blood sugar levels in people with Type 1 and Type 2 diabetes. Participation in the study will last approximately 54 weeks. ...

Phase

We are seeking volunteers who are diagnosed with Type 1 or Type 2 Diabetes and who are currently being treated with Lantus or Levemir insulin and Novolog or Humalog insulin. This study is comparing the effectiveness of an investigational meal-time (bolus) insulin to Novolog insulin. All participants will take Lantus ...

Phase